Citation 6248

ZHANG,G: SHIMOKAWA,S: MOCHIZUKI,M: KUMAMOTO,T: NAKANISHI,W: WATANABE,T: ISHIKAWA,T: MATSUMOTO,K: TASHIMA,K: HORIE,S: HIGUCHI,Y: DOMINGUEZ,OP:. (2008). CHEMICAL CONSTITUENTS OF ARISTOLOCHIA CONSTRICTA: ANTISPASMODIC EFFECTS OF ITS CONSTITUENTS IN GUINEA-PIG ILEUM AND ISOLATION OF A DITERPENO-LIGNAN HYBRID. 71(7)

Citation Details

TitleCHEMICAL CONSTITUENTS OF ARISTOLOCHIA CONSTRICTA: ANTISPASMODIC EFFECTS OF ITS CONSTITUENTS IN GUINEA-PIG ILEUM AND ISOLATION OF A DITERPENO-LIGNAN HYBRID
AuthorsZHANG,G: SHIMOKAWA,S: MOCHIZUKI,M: KUMAMOTO,T: NAKANISHI,W: WATANABE,T: ISHIKAWA,T: MATSUMOTO,K: TASHIMA,K: HORIE,S: HIGUCHI,Y: DOMINGUEZ,OP:
Year2008
Volume71
Issue7

Summary

Year: 2008

Journal: Unknown

Organisms and Their Experiments (1)

Aristolochia constricta (ARISTOLOCHIACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
VOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
KAUR-15-EN-17-OXYL,9-O-CUBEBIN:(-):
None
2Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
CUBEBIN,(-):
None
3Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
KAUR-15-EN-17-OL,(-):
None
4Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
HINOKININ,(-):
None
5Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
PLUVIATOLIDE,(-):
None
6Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
HAPLOMYRFOLOL,(-):
None
7Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
CUBEBIN,DIHYDRO: (-):
None
8Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
KAUR-16-EN-19-OIC ACID,(-):
None
9Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
KAURAN-16-ALPHA-17-DIOL,(-):
None
10Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
ARISTOLOCHIC ACID I
None
11Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
TETRAL-1-ONE,4-7-DIMETHYL-6-METHOXY:(+):
None
12Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
CADALENE
None
13Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
KAURENE,(-):
None
14Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
CUBEBIN,9-O-METHYL:
None
15Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
ARISTELEGONE A
None
16Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
CEPHARANONE B
None
17Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
KAURAN-16-ALPHA-17-18-TRIOL,(-):
None
18Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
TYRAMINE,N-(TRANS-FERULOYL):
None
19Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
SITOSTEROL,BETA: GLYCOSIDE
None
20Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
ARISTOLOLACTAM A-II
None
21
ANTISPASMOLYTIC ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITRO
None
ACTIVE
22
ANTISPASMOLYTIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
PLUVIATOLIDE,(-):HINOKININ,(-):CUBEBIN,(-):
ACTIVE
23
ANTISPASMOLYTIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
KAUR-15-EN-17-OL,(-):KAUR-15-EN-17-OXYL,9-O-CUBEBIN:(-):KAURAN-16-ALPHA-17-DIOL,(-):TETRAL-1-ONE,4-7-DIMETHYL-6-METHOXY:(+):KAUR-16-EN-19-OIC ACID,(-):CUBEBIN,DIHYDRO: (-):ARISTOLOCHIC ACID IHAPLOMYRFOLOL,(-):
INACTIVE
Show SPARQL Queries (1)